EUVIMEDEUVIMED entdecken
Systematische ÜbersichtMetaanalyseOpen Access · CC BY-NC 4.0

Efficacy of Infliximab Versus Vedolizumab in the Management of Immune Checkpoint Inhibitor-Induced Colitis: A Systematic Review and Meta-Analysis

Shreya Shambhavi, Harmanjeet Singh, Ganesh Ramaprasad, Murod Khikmatov, Varun Vankeshwaram, Kumar Ashish, Carlos Valladares, Tanushree Bhatt, Seth D Cohen

World Journal of Oncology · 2025-08 · 16 (4) · 331-341

DOI: 10.14740/wjon2613 ↗

Kurz gefasst

Systematische Übersicht in der Zeitschrift World Journal of Oncology, 2025-08. Verfasst von Shreya Shambhavi und 8 weiteren Autor:innen. Beteiligte Einrichtung: Rutgers Health/Community Medical Center, Toms River, NJ, USA. Die Arbeit wurde bisher 5-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

Stichwörter der Autor:innen

CTLA-4Immune-mediated colitisInfliximabPDL-1SteroidsVedolizumab

Autor:innen und Institutionen

  • Rutgers Health/Community Medical Center, Toms River, NJ, USA.
  • Mahatma Gandhi Memorial Medical College, Jamshedpur, Jharkhand, India.
  • Mary Washington Healthcare, Fredericksburg, VA, USA.
  • Department of Medicine, Rowan-Virtua University School of Osteopathic Medicine, Stratford, NJ 08084, USA.
  • Nazareth Hospital, Trinity-Health Mid-Atlantic, Philadelphia, PA, USA.
  • Henry Ford St. John Hospital, Detroit, MI, USA.

Zitieren

APA

Shambhavi, S., Singh, H., Ramaprasad, G., Khikmatov, M., Vankeshwaram, V., Ashish, K., Valladares, C., Bhatt, T., & Cohen, S. D. (2025). Efficacy of Infliximab Versus Vedolizumab in the Management of Immune Checkpoint Inhibitor-Induced Colitis: A Systematic Review and Meta-Analysis. World Journal of Oncology, 16(4), 331-341. https://doi.org/10.14740/wjon2613

Vancouver

Shambhavi S, Singh H, Ramaprasad G, Khikmatov M, Vankeshwaram V, Ashish K, et al. Efficacy of Infliximab Versus Vedolizumab in the Management of Immune Checkpoint Inhibitor-Induced Colitis: A Systematic Review and Meta-Analysis. World Journal of Oncology. 2025;16(4):331-341. doi:10.14740/wjon2613

BibTeX
@article{Shambhavi2025,
  author = {Shambhavi, Shreya and Singh, Harmanjeet and Ramaprasad, Ganesh and Khikmatov, Murod and Vankeshwaram, Varun and Ashish, Kumar and Valladares, Carlos and Bhatt, Tanushree and Cohen, Seth D},
  title = {Efficacy of Infliximab Versus Vedolizumab in the Management of Immune Checkpoint Inhibitor-Induced Colitis: A Systematic Review and Meta-Analysis},
  journal = {World Journal of Oncology},
  year = {2025},
  volume = {16},
  number = {4},
  pages = {331--341},
  doi = {10.14740/wjon2613}
}
Kostenlos starten →